These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 39337662)

  • 21. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
    Katz MS
    Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies.
    Stein-Merlob AF; Rothberg MV; Holman P; Yang EH
    Curr Cardiol Rep; 2021 Jan; 23(3):11. PubMed ID: 33483873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological actions of statins: a critical appraisal in the management of cancer.
    Gazzerro P; Proto MC; Gangemi G; Malfitano AM; Ciaglia E; Pisanti S; Santoro A; Laezza C; Bifulco M
    Pharmacol Rev; 2012 Jan; 64(1):102-46. PubMed ID: 22106090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiotoxicity of Contemporary Anticancer Immunotherapy.
    Dal'bo N; Patel R; Parikh R; Shah SP; Guha A; Dani SS; Ganatra S
    Curr Treat Options Cardiovasc Med; 2020; 22(12):62. PubMed ID: 33162729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of Chemotherapy Induced Cardiomyopathy.
    Payne DL; Nohria A
    Curr Heart Fail Rep; 2017 Oct; 14(5):398-403. PubMed ID: 28779279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.
    Zheng PP; Li J; Kros JM
    Med Res Rev; 2018 Jan; 38(1):325-376. PubMed ID: 28862319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins and cancer: current and future prospects.
    Osmak M
    Cancer Lett; 2012 Nov; 324(1):1-12. PubMed ID: 22542807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential of statins as part of anti-cancer treatment.
    Sleijfer S; van der Gaast A; Planting AS; Stoter G; Verweij J
    Eur J Cancer; 2005 Mar; 41(4):516-22. PubMed ID: 15737555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.
    Herrmann J
    Nat Rev Cardiol; 2020 Aug; 17(8):474-502. PubMed ID: 32231332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The statins as anticancer agents.
    Chan KK; Oza AM; Siu LL
    Clin Cancer Res; 2003 Jan; 9(1):10-9. PubMed ID: 12538446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of statins in cancer prevention and treatment.
    Stamm JA; Ornstein DL
    Oncology (Williston Park); 2005 May; 19(6):739-50; discussion 753-4. PubMed ID: 15971450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanomedicine And Nanotheranostics: Special Focus on Imaging of Anticancer Drugs Induced Cardiac Toxicity.
    Setia A; Challa RR; Vallamkonda B; Satti P; Mehata AK; Priya V; Kumar S; Muthu MS
    Nanotheranostics; 2024; 8(4):473-496. PubMed ID: 38961885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
    Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
    Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular toxicity in antitumor therapy: biological and therapeutic insights.
    Lin X; Ma X; Zhao S; Yao J; Han L; Jing Y; Xue X
    Trends Cancer; 2024 Oct; 10(10):920-934. PubMed ID: 39097431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation.
    L'Abbate S; Chianca M; Fabiani I; Del Franco A; Giannoni A; Vergaro G; Grigoratos C; Kusmic C; Passino C; D'Alessandra Y; Burchielli S; Emdin M; Cardinale DM
    J Cardiovasc Transl Res; 2022 Oct; 15(5):1143-1162. PubMed ID: 35312959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins in dermatology.
    Jowkar F; Namazi MR
    Int J Dermatol; 2010 Nov; 49(11):1235-43. PubMed ID: 20964647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of metabolic diseases in cardiotoxicity associated with cancer therapy: What we know, what we would know.
    L'Abbate S; Russo I; Kusmic C
    Life Sci; 2020 Aug; 255():117843. PubMed ID: 32464123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular mechanisms of the cardiotoxic action of anthracycline antibiotics and statin-induced cytoprotective reactions of cardiomyocytes].
    Tursunova NV; Klinnikova MG; Babenko OA; Lushnikova EL
    Biomed Khim; 2020 Sep; 66(5):357-371. PubMed ID: 33140729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.